NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Liberator Medical Holdings, Inc. (NYSE MKT:LBMH) stock prior to November 20, 2015.
You are hereby notified that a class action has been has commenced in Nevada state court challenging the fairness of the sale of Liberator Medical Holdings, Inc. to C. R. Bard, Inc. (NYSE:BCR) for $3.35 in cash per share. The claims stem from concerns that the Board of Liberator Medical may have breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and that C. R. Bard, Inc. may be underpaying for Liberator Medical shares. In particular, at least one analyst set a price target of $8.00 per Liberator Medical share. To learn more about the investigation and your rights, go to:
http://zlk.9nl.com/liberator-medical-lbmh
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 



